Lili Ye
Directeur Financier/CFO chez LONGWEN GROUP CORP.
Fortune : 1 M $ au 31/05/2024
Provenance du réseau au premier degré de Lili Ye
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Capital Normal University
4
| College/University | Other Consumer Services | 4 |
| Public Company | Financial Conglomerates | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Lili Ye via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| PEACE MAP HOLDING LIMITED | Information Technology Services | Chief Executive Officer | |
| Wuhan University | College/University | Undergraduate Degree | |
| University of Tokyo | College/University | Graduate Degree | |
| Tsinghua University | College/University | Masters Business Admin | |
| WO GROUP, INC. | Financial Conglomerates | Chief Executive Officer | |
| Capital University of Economics & Business | College/University | Undergraduate Degree | |
Beijing Peace Map Information & Technology Ltd.
 Beijing Peace Map Information & Technology Ltd. Engineering & ConstructionIndustrial Services Part of Peace Map Holding Ltd., Beijing Peace Map Information & Technology Ltd. provides aerial photography, aviation remote sensing processing, and software publication services. Zheng Wang has been the CEO of the Chinese company since 2012. | Engineering & Construction | Chief Executive Officer | |
Peace Map Co., Ltd.
 Peace Map Co., Ltd. Engineering & ConstructionIndustrial Services Part of Peace Map Holding Ltd., Peace Map Co., Ltd. provides aerial photography, aviation remote sensing, and software publication services. The company is based in Beijing, China. | Engineering & Construction | Chairman | |
Beijing Mabworks Biotech Co., Ltd.
 Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | Pharmaceuticals: Major | Director/Board Member | |
| SINO BIOLOGICAL,INC. | Pharmaceuticals: Major | Director/Board Member | |
| Beijing Humanities University | College/University | Undergraduate Degree | |
HaploX Investment Holding Ltd.
 HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Zhejiang Longwen Investment Management Co. , Ltd. | President | ||
| Hangzhou Longwen Culture & Media Co. , Ltd. | Chief Executive Officer |
Statistiques
Internationale
| Chine | 11 |
| Hong Kong | 3 |
| Japon | 2 |
| Etats-Unis | 2 |
Sectorielle
| Consumer Services | 6 |
| Industrial Services | 3 |
| Health Technology | 3 |
| Technology Services | 2 |
| Finance | 2 |
Opérationnelle
| Chief Executive Officer | 5 |
| Undergraduate Degree | 5 |
| Director/Board Member | 4 |
| Chairman | 3 |
| President | 3 |
Relations les plus connectées
| Insiders | |
|---|---|
| Hong Liang Guan | 7 |
| Xi Zhen Ye | 5 |
| Qi Li | 3 |
| Ran Gao | 2 |
| Xiao Ni Zhang | 2 |
